Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The ALS Association Oregon and SW Washington Chapter is a regional non-profit organization focused on patient advocacy, care services, and research funding for Amyotrophic Lateral Sclerosis (ALS). The entity operates as part of the national ALS Association network, facilitating access to multidisciplinary ALS clinics and providing assistive technology through equipment loan programs. While not a drug developer itself, the organization plays a critical role in the ALS ecosystem by funding clinical trials and advocating for regulatory pathways that accelerate drug approval. Its primary mission involves improving quality of life for patients in the Pacific Northwest while supporting the global search for disease-modifying therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ALS Association Oregon and SW Washington Chapter.